Sign in
Join
Automobile
Two Wheelers
Four Wheelers
Commercial-Vehicles
Aviation
Corporate
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Create an account
Privacy Policy
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Thursday, August 6, 2026
Sign in / Join
Automobile
Two Wheelers
Four Wheelers
Commercial-Vehicles
Aviation
Corporate
Facebook
Instagram
Twitter
Vimeo
Youtube
Automobile
Two Wheelers
Four Wheelers
Commercial-Vehicles
Aviation
Corporate
Search
Tags
BIOSIMILAR
Tag:
BIOSIMILAR
Healthcare
Polpharma Biologics and Tuteur Sign Licensing Agreement for a Biosimilar for Autoimmune Diseases
BFN's Desk
-
May 22, 2026
0
Healthcare
Samsung Bioepis Launches Ustekinumab Biosimilar, Marking Its First Product Launch in Japan
BFN's Desk
-
May 20, 2026
0
Healthcare
Kashiv BioSciences Agrees to Be Acquired by Amneal Pharmaceuticals to Create a Fully Integrated Global Biosimilar Leader
BFN's Desk
-
April 22, 2026
0
Healthcare
Samsung Bioepis Enters into Partnership Agreement with Sandoz for Up to Five Next-Generation Biosimilar Candidates
BFN's Desk
-
March 18, 2026
0
Healthcare
Accord Healthcare Announces Launch of Denosumab∇ – Second Biosimilar in Bone Health
BFN's Desk
-
December 2, 2025
0
Healthcare
Abbott receives regulatory approval for the first denosumab biosimilar in Thailand, expanding access to bone disease treatment
BFN's Desk
-
August 26, 2025
0
Healthcare
Accord Healthcare receives positive CHMP opinion for IMULDOSA®, ustekinumab biosimilar to Stelara®
BFN's Desk
-
October 19, 2024
0
Healthcare
FDA Approves IMULDOSA® (ustekinumab-srlf), Accord BioPharma's Biosimilar to STELARA® (ustekinumab), for the Treatment of Chronic Inflammatory Conditions
BFN's Desk
-
October 14, 2024
0
Entertainment
Biocon Biologics Successfully Completes Integration of Viatris' Biosimilar Business in 31 Countries in Europe
BFN's Desk
-
November 30, 2023
0
Insurance-Tips
pharma growth: Pharma on a very good wicket; double digit growth likely next year: Kewal Handa
BFN's Desk
-
July 31, 2023
0
Most Read
Why IndianOil’s 4-Hour LPG Delivery Could Change India’s Energy Business Forever
August 5, 2026
How IndianOil’s 4-Hour LPG Delivery Could Redefine India’s Domestic Cooking Gas Market (Part 1)
August 5, 2026
Nature’s Ally Foundation expands affordable veterinary care for Mumbai’s stray animals
August 5, 2026
Sridhar Babu to inaugurate HIPLEX 2026 in Hyderabad on August 7
August 5, 2026